Organoids to model liver disease

被引:90
|
作者
Nuciforo, Sandro [1 ]
Heim, Markus H. [1 ,2 ]
机构
[1] Univ Basel, Univ Hosp Basel, Dept Biomed, CH-4031 Basel, Switzerland
[2] Clarunis, Univ Ctr Gastrointestinal & Liver Dis, CH-4002 Basel, Switzerland
基金
欧洲研究理事会; 瑞士国家科学基金会;
关键词
Liver disease; Disease modelling; Organoids; 3D cultures; Personalised medicine; Preclinical models; PLURIPOTENT STEM-CELLS; LONG-TERM EXPANSION; IN-VITRO; ALAGILLE SYNDROME; HEPATOCYTES; CANCER; MOUSE; GENE; DIFFERENTIATION; CHOLANGIOCYTES;
D O I
10.1016/j.jhepr.2020.100198
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The organoid model represents a major breakthrough in cell biology that has revolutionised biomedical research. Organoids are 3D physiological in vitro structures that recapitulate morphological and functional features of in vivo tissues and offer significant advantages over traditional cell culture methods. Liver organoids are of particular interest because of the pleiotropy of functions exerted by the human liver, their utility to model different liver diseases, and their potential application as cell-based therapies in regenerative medicine. Moreover, because they can be derived from patient tissues, organoid models offer new perspectives in personalised medicine and drug discovery. In this review, we discuss the current liver organoid models for the study of liver disease. (C) 2020 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Augmented in vitro liver models with bioprinted liver organoids
    Congress, Zachary
    Huh, Jun Tae
    Yoo, James
    Lee, Sang Jin
    Soker, Shay
    CURRENT OPINION IN BIOMEDICAL ENGINEERING, 2024, 30
  • [42] Liver organoids: From fabrication to application in liver diseases
    Liu, Qianglin
    Zeng, Anqi
    Liu, Zibo
    Wu, Chunjie
    Song, Linjiang
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [43] Human brain organoids on a chip to model normal development and disease.
    Reiner, O.
    Karzbrun, E.
    Cohen, S.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [44] MODELING LIVER FIBROSIS IN ORGANOIDS AND LIVER-ON-A-CHIP
    Mavila, Nirmala
    Ramani, Komal
    Abeynayake, Aushinie
    HEPATOLOGY, 2022, 76 : S1264 - S1264
  • [45] Ginsenoside Rb1 improves human nonalcoholic fatty liver disease with liver organoids-on-a-chip
    Wang H.
    Zhu Y.
    Shi P.
    Li X.
    Bu Q.
    Li Y.
    You X.
    Zhao G.
    Engineered Regeneration, 2024, 5 (03): : 283 - 294
  • [46] Modeling Human Nonalcoholic Fatty Liver Disease (NAFLD) with an Organoids-on-a-Chip System
    Wang, Yaqing
    Wang, Hui
    Deng, Pengwei
    Tao, Tingting
    Liu, Haitao
    Wu, Shuo
    Chen, Wenwen
    Qin, Jianhua
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2020, 6 (10) : 5734 - 5743
  • [47] Progress, application and challenges of liver organoids
    Chen Sang
    Jian Lin
    Shuyi Ji
    Qiang Gao
    Clinical Cancer Bulletin, 3 (1):
  • [48] Liver and bile duct organoids and tumoroids
    Luo, Xuanming
    Gong, Yuda
    Gong, Zijun
    Fan, Kun
    Suo, Tao
    Liu, Han
    Ni, Xiaoling
    Ni, Xiaojian
    Abudureyimu, Miyesaier
    Liu, Houbao
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 178
  • [49] Generation of Complex Syngeneic Liver Organoids from Induced Pluripotent Stem Cells to Model Human Liver Pathophysiology
    Raggi, Claudia
    Selleri, Silvia
    M'Callum, Marie-Agnes
    Paganelli, Massimiliano
    CURRENT PROTOCOLS, 2022, 2 (03):
  • [50] Organoids for Liver Stage Malaria Research
    Mellin, Ronan
    Boddey, Justin A.
    TRENDS IN PARASITOLOGY, 2020, 36 (02) : 158 - 169